1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 30038716 | MGMT inhibition in ER positive breast cancer leads to CDC2, TOP2A, AURKB, CDC20, KIF20A, Cyclin A2, Cyclin B2, Cyclin D1, ERĪ± and Survivin inhibition and enhances response to temozolomide. | 2018 Jul 3 | 2 |